Salud financiera de hoja de balance de Wellnex Life

Salud financiera controles de criterios 3/6

Wellnex Life tiene un patrimonio de los accionistas total de A$6.1M y una deuda total de A$10.6M, lo que sitúa su ratio deuda-patrimonio en 175.2%. Sus activos y pasivos totales son A$30.9M y A$24.9M respectivamente.

Información clave

175.2%

Ratio deuda-patrimonio

AU$10.62m

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	AU$956.00k
Patrimonio	AU$6.06m
Total pasivo	AU$24.86m
Activos totales	AU$30.92m

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (A$9.9M) de WNX no cubren sus pasivos a corto plazo (A$24.8M).

Pasivo a largo plazo: Los activos a corto plazo de WNX (A$9.9M) superan a sus pasivos a largo plazo (A$86.0K).

Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de WNX (159.4%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de WNX ha crecido de 4% a 175.2% en los últimos 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: WNX tiene suficiente cash runway para 2 meses según el flujo de caja libre último declarado, pero desde entonces ha obtenido capital adicional.

Pronóstico de cash runway: Se prevé que WNX disponga de suficiente cash runway para 1 meses según las estimaciones de flujo de caja libre, aunque ha obtenido desde entonces capital adicional.

Salud financiera de hoja de balance de Wellnex Life

Salud financiera controles de criterios 3/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Wellnex Life Limited has completed a Follow-on Equity Offering in the amount of AUD 0.499999 million.

Wellnex Life Limited, Annual General Meeting, Nov 29, 2024

Investors Give Wellnex Life Limited (ASX:WNX) Shares A 35% Hiding

New major risk - Market cap size

Full year 2024 earnings released: AU$0.016 loss per share (vs AU$0.034 loss in FY 2023)

MD & Executive Director recently bought AU$250k worth of stock

Full year 2024 earnings released: AU$0.017 loss per share (vs AU$0.034 loss in FY 2023)

Wellnex Life Limited Provides Earnings Guidance for the Year 2025

Wellnex Life Limited Announces Launch of Medicinal Cannabis Brand Wellness Life

Wellnex Life Limited has completed a Follow-on Equity Offering in the amount of AUD 2.065876 million.

Wellnex Life Limited's (ASX:WNX) 29% Jump Shows Its Popularity With Investors

New major risk - Share price stability

Wellnex Life Limited (ASX:WNX) Might Not Be As Mispriced As It Looks

Wellnex Life Limited has filed a Follow-on Equity Offering in the amount of AUD 1.000028 million.

Less than half of directors are independent

Wellnex Life Limited Announces Board Appointments

It's A Story Of Risk Vs Reward With Wellnex Life Limited (ASX:WNX)

Wellnex Life Limited has completed a Follow-on Equity Offering in the amount of AUD 1.507508 million.

Wellnex Life Limited (ASX:WNX) completed the acquisition of business and assets of Pain Away from 365 Health Australia Pty Limited, Ziptime Pty Limited, One Zero Pty Limited, Twisobell Health Pty Limited.

New major risk - Shareholder dilution

Wellnex Life Limited, Annual General Meeting, Dec 14, 2023

Wellnex Life Limited has filed a Follow-on Equity Offering in the amount of AUD 13.643905 million.

Wellnex Life Limited has filed a Follow-on Equity Offering.

Wellnex Life Limited Announces Board Changes

Wellnex Life Limited Provides Revenue Guidance for the Fiscal Year 2024

Wellnex Life Limited has completed a Follow-on Equity Offering in the amount of AUD 2.2 million.

First half 2023 earnings released: AU$0.013 loss per share (vs AU$0.007 loss in 1H 2022)

Wellnex Life Limited Announces Pharmacy Own Products Update

Wellnex Life Limited Provides Revenue Guidance for the Second Half of 2023; Reaffirms Revenue Guidance for the Year 2023

Wellnex Life Limited (ASX:WNX) completed the acquisition of Mr Bright smile.

Wellnex Life Limited Reconfirms Revenue Guidance for the Fiscal Year 2023

Wellnex Announces Launch of E-Commerce Platform and Brand

Wellnex Life Limited, Annual General Meeting, Nov 29, 2022

Wellnex Life Limited Launches Two New Brands

Full year 2022 earnings released: AU$0.025 loss per share (vs AU$0.10 loss in FY 2021)

Wellnex Life Limited (ASX:WNX) entered into a binding Asset Sale Agreement to acquire Agreement to acquire for AUD 1.5 million.

Wellnex Life Limited Reaffirms Revenue Guidance for the Fiscal Year 2023

Wellnex Life Limited Reaffirms Revenue Guidance for the Fiscal Year 2023

Full year 2022 earnings released: AU$0.025 loss per share (vs AU$0.10 loss in FY 2021)

Insider recently bought AU$511k worth of stock

Wellnex Life Limited Provides Earnings Guidance for the Fiscal Year 2023

Wellnex Life Limited announced that it has received AUD 6.2 million in funding

Full year 2021 earnings released: AU$0.10 loss per share (vs AU$0.23 loss in FY 2020)

Full year 2021 earnings released: AU$0.10 loss per share (vs AU$0.23 loss in FY 2020)

Wellnex Life Limited and epharmacy Group Pty Ltd Announce the Launch of New Products Under Wagner Liquigesic Brand

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera